Listed

Medpace Holdings, Inc.

MEDPNasdaqCIK 1668397IndustrialsFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$716.0mRevenue, Q3 FY2026, three months to 2026-09-30$716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 22, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$716.0mRevenue, Q3 FY2026, three months to 2026-09-30$716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure+8.5% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin23.1%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $165.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure+1.6 pts on a year earlier
  • Net margin19.2%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $137.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure+2.4 pts on a year earlier
  • Diluted EPS$4.84Diluted EPS, Q3 FY2026, three months to 2026-09-30$4.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure+25.4% on a year earlier
  • Free cash flow$196.4mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $216.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-22, accession 0001668397-26-000036. Derived: 9-month figure less the 6-month figure.Capital expenditure: $20.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-22, accession 0001668397-26-000036. Derived: 9-month figure less the 6-month figure.Report this figure−16.6% on a year earlier

Last eight quarters

Full statements
Revenue$716.0mOperating margin 23.1%
Diluted EPS$4.84, Q3 FY2026
Free cash flow$196.4m, Q3 FY2026
Medpace Holdings, Inc., key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m537Revenue, Q4 FY2024, three months to 2024-12-31$536.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure559Revenue, Q1 FY2025, three months to 2025-03-31$558.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure603Revenue, Q2 FY2025, three months to 2025-06-30$603.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure660Revenue, Q3 FY2025, three months to 2025-09-30$659.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure708Revenue, Q4 FY2025, three months to 2025-12-31$708.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure707Revenue, Q1 FY2026, three months to 2026-03-31$706.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure707Revenue, Q2 FY2026, three months to 2026-06-30$707.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure716Revenue, Q3 FY2026, three months to 2026-09-30$716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%23.4%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $125.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Revenue: $536.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure20.3%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $113.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Revenue: $558.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure20.9%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $126.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Revenue: $603.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure21.5%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $141.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $659.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure21.6%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $153.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Revenue: $708.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure20.0%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $141.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Revenue: $706.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure20.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $146.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Revenue: $707.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure23.1%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $165.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure
Net margin%21.8%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $117.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Revenue: $536.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure20.5%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $114.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $558.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure15.0%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $90.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $603.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure16.8%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $111.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $659.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure19.1%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $135.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Revenue: $708.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure17.5%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $123.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $706.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure17.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $121.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $707.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure19.2%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $137.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Revenue: $716.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)3.67Diluted EPS, Q1 FY2025, three months to 2025-03-31$3.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure3.10Diluted EPS, Q2 FY2025, three months to 2025-06-30$3.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure3.86Diluted EPS, Q3 FY2025, three months to 2025-09-30$3.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figurenot reported (Diluted EPS not reported)4.28Diluted EPS, Q1 FY2026, three months to 2026-03-31$4.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure4.25Diluted EPS, Q2 FY2026, three months to 2026-06-30$4.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-23, accession 0001668397-26-000025.Report this figure4.84Diluted EPS, Q3 FY2026, three months to 2026-09-30$4.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-22, accession 0001668397-26-000036.Report this figure
Free cash flow$m183Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $190.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Capital expenditure: $7.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure116Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $125.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Capital expenditure: $10.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure142Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $148.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-23, accession 0001668397-26-000025. Derived: 6-month figure less the 3-month figure.Capital expenditure: $6.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-23, accession 0001668397-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure235Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $246.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-22, accession 0001668397-26-000036. Derived: 9-month figure less the 6-month figure.Capital expenditure: $10.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-22, accession 0001668397-26-000036. Derived: 9-month figure less the 6-month figure.Report this figure188Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $192.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001668397-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure145Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $151.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Capital expenditure: $6.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-23, accession 0001668397-26-000019.Report this figure138Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $162.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-23, accession 0001668397-26-000025. Derived: 6-month figure less the 3-month figure.Capital expenditure: $23.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-23, accession 0001668397-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure196Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $216.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-22, accession 0001668397-26-000036. Derived: 9-month figure less the 6-month figure.Capital expenditure: $20.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-22, accession 0001668397-26-000036. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$2.53bnOperating margin 21.1%
Diluted EPS$15.28, FY2025
Free cash flow$681.9m, FY2025
Medpace Holdings, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,142Revenue, FY2021, twelve months to 2021-12-31$1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-13, accession 0001668397-24-000013.Report this figure1,460Revenue, FY2022, twelve months to 2022-12-31$1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-11, accession 0001668397-25-000017.Report this figure1,886Revenue, FY2023, twelve months to 2023-12-31$1.89bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure2,109Revenue, FY2024, twelve months to 2024-12-31$2.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure2,530Revenue, FY2025, twelve months to 2025-12-31$2.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%17.4%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $198.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-13, accession 0001668397-24-000013.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-13, accession 0001668397-24-000013.Report this figure19.1%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $278.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-11, accession 0001668397-25-000017.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-11, accession 0001668397-25-000017.Report this figure17.9%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $336.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006.Revenue: $1.89bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure21.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $446.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006.Revenue: $2.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure21.1%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $534.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006.Revenue: $2.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure
Net margin%15.9%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $181.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-13, accession 0001668397-24-000013.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-13, accession 0001668397-24-000013.Report this figure16.8%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $245.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-11, accession 0001668397-25-000017.Revenue: $1.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-11, accession 0001668397-25-000017.Report this figure15.0%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $282.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006.Revenue: $1.89bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure19.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $404.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006.Revenue: $2.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure17.8%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $451.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001668397-26-000006.Revenue: $2.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure
Diluted EPS$ per share4.81Diluted EPS, FY2021, twelve months to 2021-12-31$4.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-13, accession 0001668397-24-000013.Report this figure7.28Diluted EPS, FY2022, twelve months to 2022-12-31$7.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-11, accession 0001668397-25-000017.Report this figure8.88Diluted EPS, FY2023, twelve months to 2023-12-31$8.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure12.63Diluted EPS, FY2024, twelve months to 2024-12-31$12.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure15.28Diluted EPS, FY2025, twelve months to 2025-12-31$15.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure
Free cash flow$m235Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $263.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-13, accession 0001668397-24-000013.Capital expenditure: $28.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-13, accession 0001668397-24-000013.Report this figure351Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $388.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-11, accession 0001668397-25-000017.Capital expenditure: $36.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-11, accession 0001668397-25-000017.Report this figure397Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $433.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001668397-26-000006.Capital expenditure: $36.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure572Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $608.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001668397-26-000006.Capital expenditure: $36.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure682Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $713.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001668397-26-000006.Capital expenditure: $31.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001668397-26-000006.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $0Sales $13.5m
Medpace Holdings, Inc., open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-27Burwig Susan EExec. VP, Operations, Officer Sale3,940$677.00$2.7mForm 4
2026-10-26Burwig Susan EExec. VP, Operations, Officer Sale16,060$677.00$10.9mForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Medpace Holdings, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$1.32bn2,498,248Added+27,808
AQR CAPITAL MANAGEMENT LLC2026-06-30$677.3m1,278,935Reduced−74,902
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$600.2m1,133,357Added+11,668
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$543.8m1,026,820Added+15,749
STATE STREET CORP2026-06-30$376.5m710,895Added+28,666
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$376.3m710,465Reduced−34,641
WASATCH ADVISORS LP2026-06-30$337.1m636,595Reduced−137,336
Invesco Ltd.2026-06-30$306.8m579,241Added+1,667
BAILLIE GIFFORD & CO2026-06-30$250.6m473,211Reduced−29,980
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2026-06-30$227.2m429,012Added+33,243

Recent filings

All 929 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Medpace Holdings, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2216:02 ET10-QQuarterly reportPeriod 2026-09-300001668397-26-000036
2026-10-2116:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001668397-26-000034
2026-09-2819:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0001193125-26-405684
2026-07-2316:03 ET10-QQuarterly reportPeriod 2026-06-300001668397-26-000025
2026-07-2216:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001668397-26-000023
2026-06-0416:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-257387
2026-05-1914:43 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-26-230425
2026-04-2316:03 ET10-QQuarterly reportPeriod 2026-03-310001668397-26-000019
2026-04-2216:15 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001668397-26-000017
2026-04-0116:38 ETDEF 14AProxy statementPeriod 2026-05-150001668397-26-000012

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 10, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1668397
Tickers
MEDP
Exchange
Nasdaq
SIC code
8731 Services-Commercial Physical & Biological Research
Sector
Industrials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.